FTC Pauses Illumina-Grail Order Amid 5th Circ. Appeal
By Piper Hudspeth Blackburn · April 25, 2023, 5:43 PM EDT
The Federal Trade Commission paused an order on Monday that would prevent biotech company Illumina from fully combining with cancer test maker Grail while the businesses appeal the agency's decision to...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login